| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/30/2008 | EP1685103B1 3-aminopyrrolidone derivatives |
| 07/30/2008 | EP1658069B1 Heterocyclic amide derivatives which possess glycogen phosphorylase inhibitory activity |
| 07/30/2008 | EP1656130B1 Omega-3 fatty acids for the treatment of canine ostheoarthritis |
| 07/30/2008 | EP1654210B1 Stilbene derivatives and their use in medicaments |
| 07/30/2008 | EP1653983A4 Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, aloe, and lemon oil |
| 07/30/2008 | EP1653943B3 Catechol derivatives for the treatment of cancer |
| 07/30/2008 | EP1633729B1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4) |
| 07/30/2008 | EP1606267B1 Pyrazine compounds as transforming growth factor (tgf) inhibitors |
| 07/30/2008 | EP1603918B1 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 07/30/2008 | EP1601652B1 Pyridinium salts, compounds and methods of use |
| 07/30/2008 | EP1583538B1 Use of 3-methoxy-pregnenolone in the production of a medicament for treating neurodegenerative diseases |
| 07/30/2008 | EP1569651B1 Tablet comprising efletirizine and pseudoephedrine |
| 07/30/2008 | EP1542973B1 2,4-substituted indoles and their use as 5-ht6 modulators |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | EP1503803B1 Injectable pharmaceutical composition comprising ethanol for treating herniated invertebral discs |
| 07/30/2008 | EP1480993B1 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/30/2008 | EP1480646B1 Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident |
| 07/30/2008 | EP1465995B1 Bispecific antisense olignucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same |
| 07/30/2008 | EP1438034B1 Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence |
| 07/30/2008 | EP1401259B1 Delta-4 desaturase genes and uses thereof |
| 07/30/2008 | EP1363654B1 Fab i and inhibition of apicomplexan parasites |
| 07/30/2008 | EP1328269B2 Association of a cb1 receptor antagonist and sibutramin for treating obesity |
| 07/30/2008 | EP1315492B1 Use of substituted pyrazoles for the treatment of allergies |
| 07/30/2008 | EP1289567B1 Lyophilizable and enhanced compacted nucleic acids |
| 07/30/2008 | EP1281398B1 Dermal compositions containing coenzyme q as the active ingredient |
| 07/30/2008 | EP1272187B1 Dopamine-d3 receptor ligands for the treatment of addiction |
| 07/30/2008 | EP1254124B1 Dipeptide nitrile cathepsin k inhibitors |
| 07/30/2008 | EP1233966B1 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
| 07/30/2008 | EP1226170B1 Human chordin and polynucleotides encoding the same |
| 07/30/2008 | EP1064009B2 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects |
| 07/30/2008 | EP1059927B1 Chemical compounds and their use to elevate pyruvate dehydrogenase activity |
| 07/30/2008 | EP1054881B1 Novel sulfonamide substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 07/30/2008 | EP1041977B1 Use of ppar-gamma activators for treating dermatological disorders |
| 07/30/2008 | EP1028118B1 Process for producing 3-cephem compounds |
| 07/30/2008 | EP1025124B1 Low-toxicity human interferon-alpha analogues |
| 07/30/2008 | EP0994728B1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof |
| 07/30/2008 | EP0968713B1 Plasters containing isosorbide nitrate |
| 07/30/2008 | EP0912738B1 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 07/30/2008 | CN101233147A Macrocyclic inhibitors of hepatitis c virus |
| 07/30/2008 | CN101233145A Agent for amelioration of insulin resistance |
| 07/30/2008 | CN101233141A Ascomycin crystalline forms and preparation thereof |
| 07/30/2008 | CN101233140A Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 07/30/2008 | CN101233139A Alpha-(aryl-or heteroaryl-methyl)-beta-piperidinopropanoic acid compounds as ORL1-receptor antagonists |
| 07/30/2008 | CN101233136A Pyrrolotriazine compounds useful as kinase inhibitors and methods of treating kinase-associated conditions therewith |
| 07/30/2008 | CN101233133A Hydrochlorides and hydrates of 1-[(3-cyanopyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-yl)xanthine, their preparation and their use as medicaments |
| 07/30/2008 | CN101233132A Compounds for modulating TRPV3 function |
| 07/30/2008 | CN101233131A Macrocyclic inhibitors of hepatitis c virus |
| 07/30/2008 | CN101233130A Diazine azole derivatives, their manufacture and use as pharmaceutical agents |
| 07/30/2008 | CN101233125A Antitumoral compounds |
| 07/30/2008 | CN101233124A Glycolipid derivative and therapeutic agent comprising the same as active ingredient |
| 07/30/2008 | CN101233119A Novel heterocyclic nf-kb inhibitors |
| 07/30/2008 | CN101233114A New imidazole carboxamides, useful to treat e.g. pathologies associated with the insulin resistance syndrome, are fructose-1,6-biphosphatase inhibitors |
| 07/30/2008 | CN101233113A Cycloalkyl amino-hydantoin compounds and use thereof for beta-secretase modulation |
| 07/30/2008 | CN101233111A Amorphous salt of 4-(3-chiloro-4-(cycloproplylaminocarbonyl)aminophenoxy)-7-method-6-quinolinecarboxamide and process for preparing the same |
| 07/30/2008 | CN101233110A Substance with oxidation resistance, agedness protection and anti-ischemia active and preparing method thereof |
| 07/30/2008 | CN101233109A N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators |
| 07/30/2008 | CN101233108A Cyclic amine derivative having substituted alkyl group |
| 07/30/2008 | CN101233107A Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases |
| 07/30/2008 | CN101233106A Thiomorpholine compound and process for preparing the same |
| 07/30/2008 | CN101233105A Tryptophan derivative and use thereof |
| 07/30/2008 | CN101233104A Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
| 07/30/2008 | CN101233103A Cyanopyrrole-phenyl amide progesterone receptor modulators and uses thereof |
| 07/30/2008 | CN101233100A An impurity of anastrozole intermediate, and uses thereof |
| 07/30/2008 | CN101232902A Noninvasive drug delivery system to posterior part tissue of eye by using solid composition |
| 07/30/2008 | CN101232901A Joint use of sulfonamide based compound with angiogenesis inhibitor |
| 07/30/2008 | CN101232894A Anticancer agent to be combined with telomelysin |
| 07/30/2008 | CN101232892A Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors |
| 07/30/2008 | CN101232891A Agent for enhancing collagen production and utilization of the same |
| 07/30/2008 | CN101232890A Methods of preparing heterocyclic boronic acids and derivatives thereof |
| 07/30/2008 | CN101232889A Enhancer of the effect of adrenocorticoid, comprising gum arabic |
| 07/30/2008 | CN101232888A Treatment of amyotrophic lateral sclerosis with norethindrone and analogues |
| 07/30/2008 | CN101232887A Heterocyclic benzodiazepine CGRP receptor antagonists |
| 07/30/2008 | CN101232886A Methods of using potassium channel inhibiting compounds |
| 07/30/2008 | CN101232885A Substituted pyridazinyl- and pyrimidinyl-quinolin-4-ylamine analogues |
| 07/30/2008 | CN101232884A Quinoline derivatives as antibacterial agents |
| 07/30/2008 | CN101232883A Use of thienopyridone derivatives as ampk activators and pharmaceutical compositions containing them |
| 07/30/2008 | CN101232882A Percutaneously absorbable ophthalmic preparation |
| 07/30/2008 | CN101232881A Bicyclic 6-alkylidene-penem beta-lactamase inhibitors and beta-lactam antibiotic combination: a broad spectrum antibiotic |
| 07/30/2008 | CN101232880A Use of HDAC inhibitors for the treatment of myeloma |
| 07/30/2008 | CN101232879A Compounds having anti-cancer properties |
| 07/30/2008 | CN101232878A Method of modulating T cell functioning |
| 07/30/2008 | CN101232877A N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress |
| 07/30/2008 | CN101232876A Transdermal system for varenicline |
| 07/30/2008 | CN101232872A Formulations for 7-(t-butoxy)iminomethyl camptothecin |
| 07/30/2008 | CN101232871A Tocopheryl polyethylene glycol succinate powder and process for preparing same |
| 07/30/2008 | CN101232870A Nanoparticulate imatinib mesylate formulations |
| 07/30/2008 | CN101232868A Combination of tramadol and substances that comprise gabapentin |
| 07/30/2008 | CN101232867A Cosmetic and/or dermatological composition for prevention and/or treatment of sensitive or dry skin |
| 07/30/2008 | CN101232807A Compositions having a high antiviral and antibacterial efficacy |
| 07/30/2008 | CN101232806A Synergistic effects of combined administration of mirtazapine and a stimulant compound |
| 07/30/2008 | CN101231233A Method for controlling release velocity of fluorescent probe molecule in emulsions |
| 07/30/2008 | CN101230336A Gm-negative ehv-mutants |
| 07/30/2008 | CN101230331A Use of baicalin in promoting vitro directional differentiation of mesenchymal stem cells and method thereof |
| 07/30/2008 | CN101230096A Peptide derived from hepatitis C virus |
| 07/30/2008 | CN101230083A Novel glycyrrhetinic acid derivatives and preparation method thereof |
| 07/30/2008 | CN101230082A 23-hydroxy betulinic acid derivative, preparation method, preparation and use thereof |
| 07/30/2008 | CN101230081A Extraction method for separating antineoplastic tri-terpenoid from capsule of weeping forsythia and use thereof |
| 07/30/2008 | CN101230079A 1,2-glycoside transderivative of oxazole compounds and preparation method thereof |
| 07/30/2008 | CN101230074A Phosphate derivative of oxazole compounds and preparation method thereof |
| 07/30/2008 | CN101230070A Novel anti-infection cephalosporin compounds |